MARCIA TIMMONS: Open Payments
NPI 1336792886 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 39 payments from 13 companies in 2025. Trend: 2023 $944 · 2024 $923 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $205 |
| Novo Nordisk Inc | 9 | $156 |
| PFIZER INC. | 6 | $111 |
| ABBVIE INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
Products named: AIRSUPRA, Wegovy, NURTEC ODT, FARXIGA, Rybelsus, ELIQUIS, ACCRUFER, Ozempic.
Industry payments across GA — which companies pay providers there.
